Lakewood-Amedex Biotherapeutics(LABT.US)

Last Updated 19:00:00 ET
longbridge loading

Lakewood-Amedex Stock Falls Despite Positive Nu-3 Manufacturing Update

Fidelity·
US
LABT
-9.62%
Fidelity·
US
LABT
-9.62%

Lakewood-Amedex Biotherapeutics Announces Positive Data for the Advancement of Lead Candidate, Nu-3, in Infected Diabetic Foot Ulcers | LABT Stock News

StockTitan·
US
LABT
-9.62%
StockTitan·
US
LABT
-9.62%

Lakewood-Amedex (LABT.US) Surges 25% Intraday

Movers Alert·
US
LABT
-9.62%
Movers Alert·
US
LABT
-9.62%

Lakewood-Amedex Soars Over 53% Amid Board Appointment

Movers Alert·
US
LABT
-9.62%
Movers Alert·
US
LABT
-9.62%

Pre-market hot trades in US stocks: Lakewood-Amedex Biotherapeutics up 54.51% in pre-market; Galaxy Digital up 3.00% in pre-market

Price Alert·
US
LABT
-9.62%
US
GLXY
+3.30%
Price Alert·
US
LABT
-9.62%
US
GLXY
+3.30%

Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors | ENVB Stock News

StockTitan·
US
ENVB
+1.18%
US
IBB
+1.70%
US
BBH
+0.22%
StockTitan·
US
ENVB
+1.18%
US
IBB
+1.70%
US
BBH
+0.22%
© 2026 Longbridge｜Disclaimer